Summary
Updated Aug 30, 2026
Laura Hamill is Director of Jazz Pharmaceuticals plc (JAZZ). 5 SEC Form 4 filings on record going back to 2025, most recently on 7 August 2026.
Recent Transactions
6Every recent SEC Form 4 transaction Laura Hamill has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Laura Hamill files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bruce C. Cozadd - $26.42M of JAZZ open-market activity in the last 12 months
- Neena M. Patil - $11.21M of JAZZ open-market activity in the last 12 months
- Patricia Carr - $1.66M of JAZZ open-market activity in the last 12 months
- Rick E. Winningham - $1.66M of JAZZ open-market activity in the last 12 months
- Samantha Pearce - $1.63M of JAZZ open-market activity in the last 12 months
- Robert Iannone - $1.20M of JAZZ open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Laura Hamill?
Laura Hamill is a corporate insider, tracked as Director of Jazz Pharmaceuticals plc (JAZZ). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Laura Hamill submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Laura Hamill's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Laura Hamill and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
